Aadi Bioscience Stock Buy Hold or Sell Recommendation
| AADI Stock | USD 2.30 0.02 0.88% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Aadi Bioscience is 'Strong Sell'. The recommendation algorithm takes into account all of Aadi Bioscience's available fundamental, technical, and predictive indicators you will find on this site.
Check out Aadi Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide. In addition, we conduct extensive research on individual companies such as Aadi and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Aadi |
Execute Aadi Bioscience Buy or Sell Advice
The Aadi recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aadi Bioscience. Macroaxis does not own or have any residual interests in Aadi Bioscience or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aadi Bioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Aadi Bioscience Trading Alerts and Improvement Suggestions
| The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (18.78 M). | |
| Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: BML Capital Management LLC Takes 4.12 Million Position in Aadi Bioscience, Inc. - MarketBeat |
Aadi Bioscience Returns Distribution Density
The distribution of Aadi Bioscience's historical returns is an attempt to chart the uncertainty of Aadi Bioscience's future price movements. The chart of the probability distribution of Aadi Bioscience daily returns describes the distribution of returns around its average expected value. We use Aadi Bioscience price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aadi Bioscience returns is essential to provide solid investment advice for Aadi Bioscience.
| Mean Return | 0.63 | Value At Risk | -3.87 | Potential Upside | 5.46 | Standard Deviation | 2.90 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aadi Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aadi Stock Institutional Investors
| Shares | Goldman Sachs Group Inc | 2024-06-30 | 154.3 K | Jane Street Group Llc | 2024-06-30 | 134.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 129.8 K | Susquehanna International Group, Llp | 2024-06-30 | 99.9 K | Verition Fund Managegment, Llc | 2024-06-30 | 82.4 K | 683 Capital Management Llc | 2024-06-30 | 80 K | Ubs Group Ag | 2024-06-30 | 70.4 K | State Street Corp | 2024-06-30 | 68.7 K | Northern Trust Corp | 2024-09-30 | 68.5 K | Venbio Select Advisor Llc | 2024-09-30 | 2.8 M | Bml Capital Management Llc | 2024-09-30 | 2 M |
Aadi Bioscience Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (24.1M) | (11.5M) | 144.5M | (109.9M) | 23.9M | 25.1M | |
| Free Cash Flow | (24.1M) | (12.7M) | (22.5M) | (50.1M) | (63.6M) | (60.5M) | |
| Capital Expenditures | 237.0K | 19.0K | 46K | 444K | 4.0M | 4.2M | |
| End Period Cash Flow | 38.5M | 4.5M | 149.0M | 39.1M | 63.0M | 66.1M | |
| Other Non Cash Items | 3.6M | 982K | 836K | 2.9M | (2.6M) | (2.5M) | |
| Net Income | (23.3M) | (3.5M) | (110.1M) | (60.5M) | (65.8M) | (62.5M) | |
| Depreciation | 76.5K | 9K | 105K | 159K | 169K | 90.9K | |
| Change To Netincome | 301.5K | 1.3M | 2.9M | 12.5M | 14.4M | 15.1M |
Aadi Bioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aadi Bioscience or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aadi Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aadi stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.48 | |
β | Beta against Dow Jones | 1.37 | |
σ | Overall volatility | 2.64 | |
Ir | Information ratio | 0.18 |
Aadi Bioscience Volatility Alert
Aadi Bioscience currently demonstrates below-average downside deviation. It has Information Ratio of 0.18 and Jensen Alpha of 0.48. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aadi Bioscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aadi Bioscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Aadi Bioscience Fundamentals Vs Peers
Comparing Aadi Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aadi Bioscience's direct or indirect competition across all of the common fundamentals between Aadi Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aadi Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aadi Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aadi Bioscience to competition |
| Fundamentals | Aadi Bioscience | Peer Average |
| Return On Equity | -0.66 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Profit Margin | (2.46) % | (1.27) % |
| Operating Margin | (1.49) % | (5.51) % |
| Current Valuation | (5.48 M) | 16.62 B |
| Shares Outstanding | 24.65 M | 571.82 M |
| Shares Owned By Insiders | 9.96 % | 10.09 % |
| Shares Owned By Institutions | 49.06 % | 39.21 % |
| Number Of Shares Shorted | 281.12 K | 4.71 M |
| Price To Book | 0.82 X | 9.51 X |
| Price To Sales | 2.24 X | 11.42 X |
| Revenue | 24.35 M | 9.43 B |
| Gross Profit | (18.78 M) | 27.38 B |
| EBITDA | (65.36 M) | 3.9 B |
| Net Income | (65.77 M) | 570.98 M |
| Cash And Equivalents | 118.74 M | 2.7 B |
| Cash Per Share | 5.65 X | 5.01 X |
| Total Debt | 1.27 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 9.87 X | 2.16 X |
| Book Value Per Share | 2.80 X | 1.93 K |
| Cash Flow From Operations | (59.66 M) | 971.22 M |
| Short Ratio | 3.24 X | 4.00 X |
| Earnings Per Share | (2.28) X | 3.12 X |
| Target Price | 1.88 | |
| Number Of Employees | 53 | 18.84 K |
| Beta | 0.37 | -0.15 |
| Market Capitalization | 56.2 M | 19.03 B |
| Total Asset | 132.42 M | 29.47 B |
| Retained Earnings | (268.96 M) | 9.33 B |
| Working Capital | 98.19 M | 1.48 B |
| Net Asset | 132.42 M |
Note: Acquisition by Dalal Anupam of 18573 shares of Aadi Bioscience at 13.46 subject to Rule 16b-3 [view details]
Aadi Bioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aadi . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1904.65 | |||
| Daily Balance Of Power | 0.25 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 2.29 | |||
| Day Typical Price | 2.29 | |||
| Price Action Indicator | 0.02 | |||
| Period Momentum Indicator | 0.02 |
About Aadi Bioscience Buy or Sell Advice
When is the right time to buy or sell Aadi Bioscience? Buying financial instruments such as Aadi Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aadi Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Aadi Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share 0.929 | Quarterly Revenue Growth 0.21 | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.